4.6 Article

Heart failure and catheter ablation of atrial fibrillation: Navigating the difficult waters of heart failure phenotypes

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Cardiac & Cardiovascular Systems

Management of Hypertrophic Cardiomyopathy JACC State-of-the-Art Review

Barry J. Maron et al.

Summary: Hypertrophic cardiomyopathy (HCM), a common and often inherited primary cardiac disease, can be effectively treated with various options that significantly improve patient outcomes. Innovations in risk stratification, surgical intervention, anticoagulation prophylaxis, and ablation techniques have reduced morbidity and mortality rates. Palliative pharmacological strategies can control symptoms in the short-term, but have limited impact on long-term clinical course.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2022)

Review Cardiac & Cardiovascular Systems

Catheter ablation for atrial fibrillation: current indications and evolving technologies

Ramanathan Parameswaran et al.

Summary: Catheter ablation is a key strategy for managing atrial fibrillation, with technological advancements focusing on improving safety and effectiveness. Guidelines recommend the procedure for symptomatic patients with paroxysmal or persistent AF, but evidence from trials is mixed. Pulmonary vein isolation remains a cornerstone technique in AF ablation, with ongoing developments in technology aimed at enhancing patient outcomes.

NATURE REVIEWS CARDIOLOGY (2021)

Article Cardiac & Cardiovascular Systems

A randomized ablation-based atrial fibrillation rhythm control versus rate control trial in patients with heart failure and high burden atrial fibrillation: The RAFT-AF trial rationale and design

Ratika Parkash et al.

Summary: The study aims to determine whether catheter ablation treatment for AF in HF patients can reduce all-cause mortality and hospitalizations for HF.

AMERICAN HEART JOURNAL (2021)

Article Cardiac & Cardiovascular Systems

Exercise Stress Real-Time Cardiac Magnetic Resonance Imaging for Noninvasive Characterization of Heart Failure With Preserved Ejection Fraction The HFpEF-Stress Trial

Soeren J. Backhaus et al.

Summary: Real-time cardiac magnetic resonance (RT-CMR) exercise imaging can accurately diagnose HFpEF, providing a suitable noninvasive diagnostic alternative, which may be beneficial for routine clinical use pending further multicenter studies.

CIRCULATION (2021)

Review Cardiac & Cardiovascular Systems

Diagnosis and treatment of cardiac amyloidosis: position statement of the German Cardiac Society (DGK)

A. Yilmaz et al.

Summary: Systemic forms of amyloidosis affecting the heart primarily involve light-chain (AL) and transthyretin (ATTR) amyloidoses. Modern diagnostic methods such as specific serum biomarkers and non-invasive imaging techniques allow for accurate assessment of cardiac involvement, with endomyocardial biopsy still playing a key role. The main goal is to detect and diagnose cardiac amyloidosis early, determine its extent, and identify the subtype for targeted treatment.

CLINICAL RESEARCH IN CARDIOLOGY (2021)

Article Cardiac & Cardiovascular Systems

Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure Results From the CABANA Trial

Douglas L. Packer et al.

Summary: The CABANA trial showed that catheter ablation in patients with heart failure and atrial fibrillation can significantly improve survival, reduce AF recurrence, and enhance quality of life compared to drug therapy.

CIRCULATION (2021)

Article Cardiac & Cardiovascular Systems

A prospective STudy using invAsive haemodynamic measurements foLLowing catheter ablation for AF and early HFpEF: STALL AF-HFpEF

Hariharan Sugumar et al.

Summary: This study found that atrial fibrillation ablation in early heart failure patients can improve symptoms and exercise hemodynamic parameters. Restoration of sinus rhythm in patients with AF and HFpEF can lead to improvements in haemodynamic parameters and symptoms.

EUROPEAN JOURNAL OF HEART FAILURE (2021)

Article Cardiac & Cardiovascular Systems

Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure

Biykem Bozkurt et al.

Summary: This document proposes a universal definition of heart failure as a clinical syndrome and revised stages of HF, as well as a new classification based on left ventricular ejection fraction (LVEF) levels. The classification includes HFrEF, HFmrEF, HFpEF, and HFimpEF based on LVEF percentages.

EUROPEAN JOURNAL OF HEART FAILURE (2021)

Article Medicine, General & Internal

Atrial Fibrillation

Gregory F. Michaud et al.

Summary: A 63-year-old healthy male with atrial fibrillation presents with symptoms of dyspnea and irregular heartbeat. Physical examination reveals high blood pressure, irregular pulse, and ECG confirms atrial fibrillation. Further evaluation and treatment plan are needed.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Cardiac & Cardiovascular Systems

Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases

Pablo Garcia-Pavia et al.

Summary: Cardiac amyloidosis is a serious and progressive infiltrative disease caused by the deposition of amyloid fibrils in the heart. With advances in imaging techniques and non-invasive diagnosis, it is now recognized as more common than traditionally believed. The Working Group on Myocardial and Pericardial Disease has proposed definitions, diagnostic algorithms, and treatment strategies to help bridge the gap between the latest research and clinical practice in managing cardiac amyloidosis.

EUROPEAN JOURNAL OF HEART FAILURE (2021)

Article Cardiac & Cardiovascular Systems

Early Rhythm Control Therapy in Patients With Atrial Fibrillation and Heart Failure

Andreas Rillig et al.

Summary: The study demonstrates that early rhythm control therapy is beneficial in reducing cardiovascular events in patients with heart failure and atrial fibrillation. Additionally, the therapy helps to improve left ventricular ejection fraction in heart failure patients.

CIRCULATION (2021)

Article Cardiac & Cardiovascular Systems

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Theresa A. McDonagh et al.

EUROPEAN HEART JOURNAL (2021)

Editorial Material Medicine, General & Internal

Advancing the Learning Health System

J. Michael McGinnis et al.

Summary: By recognizing the potential of technological and methodological advances to improve the pace, generalizability, and costs of innovation in health and medicine, the National Academy of Medicine has facilitated the evolution of a continuously learning health system.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Letter Cardiac & Cardiovascular Systems

Transthyretin Cardiac Amyloidosis in the Elderly-Tip of a Heart Failure Iceberg?

Lars G. Svensson et al.

JAMA CARDIOLOGY (2021)

Letter Cardiac & Cardiovascular Systems

Transthyretin CardiacAmyloidosis in the Elderly-Tip of a Heart Failure Iceberg?

Lars G. Svensson et al.

JAMA CARDIOLOGY (2021)

Article Cardiac & Cardiovascular Systems

Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure

Biykem Bozkurt et al.

Summary: This document proposes a universal definition, revised stages, and new classification of heart failure based on left ventricular ejection fraction. The classification includes HF with reduced, mildly reduced, preserved, and improved ejection fraction, each with specific LVEF thresholds.

EUROPEAN JOURNAL OF HEART FAILURE (2021)

Article Cardiac & Cardiovascular Systems

Atrial fibrillation ablation in patients with transthyretin cardiac amyloidosis

Eoin Donnellan et al.

EUROPACE (2020)

Editorial Material Cardiac & Cardiovascular Systems

Research Day of the Royal Brompton and Harefield Hospitals, Royal Society of Medicine, London

Thomas F. Luescher

EUROPEAN HEART JOURNAL (2020)

Article Cardiac & Cardiovascular Systems

Discrepancy in recognition of symptom burden among patients with atrial fibrillation

Yoshinori Katsumata et al.

AMERICAN HEART JOURNAL (2020)

Article Cardiac & Cardiovascular Systems

Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association

Michelle M. Kittleson et al.

CIRCULATION (2020)

Article Cardiac & Cardiovascular Systems

Catheter Ablation for Atrial Fibrillation in Patients With Concurrent Heart Failure

Shilpkumar Arora et al.

AMERICAN JOURNAL OF CARDIOLOGY (2020)

Review Cardiac & Cardiovascular Systems

JCS 2020 Guideline on Diagnosis and Treatment of Cardiac Amyloidosis

Hiroaki Kitaoka et al.

CIRCULATION JOURNAL (2020)

Article Medicine, General & Internal

Early Rhythm-Control Therapy in Patients with Atrial Fibrillation

Paulus Kirchhof et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Cardiac & Cardiovascular Systems

2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy

Steve R. Ommen et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Article Health Care Sciences & Services

Digitizing clinical trials

O. T. Inan et al.

NPJ DIGITAL MEDICINE (2020)

Article Cardiac & Cardiovascular Systems

Atrial fibrillation ablation in practice: assessing CABANA generalizability

Peter A. Noseworthy et al.

EUROPEAN HEART JOURNAL (2019)

Article Medicine, General & Internal

Effect of Catheter Ablation vs Antiarrhythmic Medication on Quality of Life in Patients With Atrial Fibrillation The CAPTAF Randomized Clinical Trial

Carina Blomstrom-Lundqvist et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)

Article Medicine, General & Internal

Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial Fibrillation The CABANA Randomized Clinical Trial

Daniel B. Mark et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)

Article Cardiac & Cardiovascular Systems

Heart Failure With Preserved Ejection Fraction In Perspective

Marc A. Pfeffer et al.

CIRCULATION RESEARCH (2019)

Editorial Material Cardiac & Cardiovascular Systems

Atrial fibrillation: thinking beyond thromboembolism

Yogesh N. V. Reddy et al.

EUROPEAN JOURNAL OF HEART FAILURE (2019)

Review Medicine, General & Internal

Catheter Ablation of Atrial Fibrillation in Patients With Heart Failure A Meta-analysis of Randomized Controlled Trials

Mohit K. Turagam et al.

ANNALS OF INTERNAL MEDICINE (2019)

Review Cardiac & Cardiovascular Systems

Atrial fibrillation ablation in heart failure

Sergio Richter et al.

EUROPEAN HEART JOURNAL (2019)

Article Cardiac & Cardiovascular Systems

Catheter Ablation Versus Best Medical Therapy in Patients With Persistent Atrial Fibrillation and Congestive Heart Failure The Randomized AMICA Trial

Karl-Heinz Kuck et al.

CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2019)

Article Medicine, General & Internal

Catheter Ablation for Atrial Fibrillation with Heart Failure

Nassir F. Marrouche et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Cardiac & Cardiovascular Systems

Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy

Ethan J. Rowin et al.

CIRCULATION (2017)

Editorial Material Cardiac & Cardiovascular Systems

Atrial Fibrillation in Heart Failure: Should Catheter Ablation Play a Larger Role?

Bruce A. Koplan et al.

CIRCULATION (2016)

Article Cardiac & Cardiovascular Systems

Catheter Ablation for Atrial Arrhythmias in Patients With Cardiac Amyloidosis

Nicholas Y. Tan et al.

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2016)

Review Medicine, General & Internal

Pragmatic Trials

Ian Ford et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)